NCT01080859

Vessel Wall Response of the Bio-Active-stent and Everolimus-Eluting Stent Assessed By Optical Coherence Tomography

Early Coverage and Vessel Wall Response of the Bio-Active-stent and Everolimus-Eluting Stent Implanted in Acute Coronary Syndrome Assessed By Optical Coherence Tomography (BASE-OCT)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 40 (estimated)
• Sponsor: The Hospital District of Satakunta · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the trial is to evaluate the completeness of struts coverage and vessel wall response (strut malapposition, neoin-timal formation) to the bio-active-stent (BAS) versus ever-olimus-eluting stent (EES) implanted for the treatment of the culprit lesion in acute coronary syndrome.

Detailed description

A prospective, randomized and controlled study comparing the coverage of the BAS and EES implanted in acute coronary syndrome. Clinical follow-up at 1, 6, 12 and 18 months. OCT analysis at the time of the 6 to 8 months follow-up.

Conditions

• Acute Coronary Syndrome

Interventions

Type	Name	Description
DEVICE	OCT	Optical coherence tomography
DEVICE	OCT	Optical coherence tomography

Timeline

• Start date: 2009-12-01
• Primary completion: 2011-05-01
• Completion: 2011-05-01
• First posted: 2010-03-04
• Last updated: 2011-05-05

Locations

1 site across 1 country: Finland